甲磺酸伊马替尼对涉及血小板衍生生长因子受体β的非典型慢性髓性白血病有积极的临床反应。 - Suppr

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta.

作者信息

Garcia Juan L, Font de Mora Jaime, Hernandez Jesus M, Queizan Jose A, Gutierrez Norma C, Hernandez Jose M, San Miguel Jesus F

出版信息

Blood. 2003 Oct 1;102(7):2699-700. doi: 10.1182/blood-2003-05-1579.

DOI:10.1182/blood-2003-05-1579

PMID:14504072

Abstract

摘要

相似文献

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta.甲磺酸伊马替尼对涉及血小板衍生生长因子受体β的非典型慢性髓性白血病有积极的临床反应。

Blood. 2003 Oct 1;102(7):2699-700. doi: 10.1182/blood-2003-05-1579.

Pregnancy in patients with chronic myeloid leukemia treated with imatinib.接受伊马替尼治疗的慢性髓性白血病患者的妊娠情况。

Leuk Lymphoma. 2007 Dec;48(12):2454-6. doi: 10.1080/10428190701658751.

Chronic myeloid leukemia. Sceptical scientists.慢性髓性白血病。持怀疑态度的科学家。

Lancet. 2001 Dec;358 Suppl:S11. doi: 10.1016/s0140-6736(01)07024-6.

Chromosomal abnormalities in Ph- cells of patients on imatinib.

Blood. 2003 Oct 1;102(7):2700-1; author reply 2701. doi: 10.1182/blood-2003-06-1943.

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia.慢性髓性白血病中hOCT1转录水平和单核苷酸多态性作为伊马替尼反应的预测因素

Leukemia. 2010 Jun;24(6):1243-5. doi: 10.1038/leu.2010.86. Epub 2010 May 6.

Imatinib mesylate: a new pill for chronic myelogenous leukemia.

Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

[Treatment of chronic myelogenous leukemia by using imatinib].[使用伊马替尼治疗慢性粒细胞白血病]

Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1819-24. doi: 10.2169/naika.94.1819.

Chromosomal abnormalities in chronic myeloid leukemia: evidence of a hierarchy in imatinib treated cells.慢性髓性白血病中的染色体异常：伊马替尼治疗细胞中存在等级结构的证据。

Leuk Lymphoma. 2007 May;48(5):1029-31. doi: 10.1080/10428190701200034.

Discontinuing imatinib in chronic myeloid leukemia: don't try this at home.慢性粒细胞白血病中停用伊马替尼：请勿在家自行尝试。

Leuk Lymphoma. 2009 Jun;50(6):868-70. doi: 10.1080/10428190902934951.

Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.接受甲磺酸伊马替尼治疗的慢性髓性白血病患者的色素沉着变化。

Ann Oncol. 2004 Feb;15(2):358-9. doi: 10.1093/annonc/mdh068.

引用本文的文献

Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis.美国非典型慢性髓性白血病患者的特征及生存结果：一项基于监测、流行病学和最终结果（SEER）数据库的分析

Leuk Res Rep. 2023 Aug 6;20:100383. doi: 10.1016/j.lrr.2023.100383. eCollection 2023.

Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.伴CCDC6-PDGFRB融合基因新断点的t(5;10)(q33;q22)的PDGFRB重排的髓系/淋系肿瘤

Intern Med. 2019 Dec 1;58(23):3449-3453. doi: 10.2169/internalmedicine.3220-19. Epub 2019 Jul 22.

PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.一名37岁男性的伴有显著嗜酸性粒细胞增多的血小板衍生生长因子受体β重排的髓系肿瘤；文献综述

Am J Case Rep. 2017 Feb 17;18:173-180. doi: 10.12659/ajcr.900623.

Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database.BCR/ABL阴性慢性髓性白血病的特征与生存情况：基于监测、流行病学及最终结果数据库的回顾性分析

Ther Adv Hematol. 2015 Dec;6(6):308-12. doi: 10.1177/2040620715607416.

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib.携带 PDGFRB 融合基因的髓系恶性肿瘤患者使用伊马替尼可获得持久的长期缓解。

Blood. 2014 Jun 5;123(23):3574-7. doi: 10.1182/blood-2014-02-555607. Epub 2014 Mar 31.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献